This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Top European Pathologist Joins RUSVM To Lead New Postgraduate Degree Programs

Stocks in this article: DV

Ross University School of Veterinary Medicine (RUSVM) announced the appointment of Dr. Sean Callanan as director of postgraduate studies who will oversee RUSVM’s first postgraduate degree programs focused in research. RUSVM has been awarding veterinary medicine degrees since 1982 and will now expand its programs to include master’s and doctoral degrees.

The new degree programs provide opportunities for students with science or veterinary educational backgrounds to specialize in global issues related to human-animal interactions, such as diseases that transfer between species. Courses of study include wildlife conservation and tropical animal health. Students will benefit from the school’s location in St. Kitts, an island in the West Indies, where they will be able to work with animals that live in a wide range of ecosystems.

“My intention is to ensure strong mentorship, equip students with the ability to problem solve and encourage their curiosity to pursue complex research questions,” Dr. Callanan said. “I’m very excited to be given the opportunity to lead this new initiative in a school that is currently establishing itself as the leading animal-health research and training institute in the region.”

Dr. Callanan completed his degree in veterinary medicine at the University College Dublin in his native Ireland and received his Ph.D. degree and pathology training from the University of Glasgow in Scotland. He has a strong interest in neuroscience and is well-known for his discovery and characterization of a new neuroinflammatory disorder in Irish greyhounds.

Much of Dr. Callanan’s research has focused on feline immunodeficiency virus (FIV), which is recognized as a model for HIV infection in humans. His early work revealed that within weeks of infection, FIV can cross the blood-brain barrier; once the virus infects the brain it can avoid drug therapies and multiply unchecked. His pioneering work also includes collaborations with Trinity College Dublin on the evaluation of novel therapies for human neurodegenerative disorders.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs